Table 3.
Receipt of treatment for initial breast cancer diagnosis in the cohort of 934 women by breast cancer molecular subtype
| Luminal A (N=615) | Luminal B (N=42) | Basal-like (N=210) | HER2- enriched (N=67) | |||||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | |
| Treatmenta | ||||||||
| Surgery | 615 | 42.4 | 42 | 38.5 | 210 | 44.7 | 67 | 44.9 |
| Radiation | 252 | 17.4 | 21 | 19.3 | 69 | 14.7 | 18 | 12.1 |
| Chemotherapy | 231 | 15.9 | 23 | 21.1 | 136 | 28.9 | 49 | 32.9 |
| Tamoxifen | 352 | 24.3 | 23 | 21.1 | 55 | 11.7 | 15 | 10.1 |
Column percent’s exceed 100% due to multiple treatments